Breast cancer test maker Agendia has released new data suggesting its MammaPrint genomic diagnostic spots breast cancer patients with ultra-low risk of recurrence, who could skip chemo and are likely to keep cancer at bay for at least 20 years. This information, culled from an analysis of 70 different genes, could help oncologists tailor treatment plans for certain early-stage breast cancer cases,…
Radicle Science and Rae Wellness have recently announced a new CBD study focused exclusively on CBD and Women’s Health. The Rae Wellness study on CBD and Women’s Health is one of the first and largest randomized, controlled human studies to evaluate the effects of commercially available non-prescription CBD products. To our knowledge, it represents the first CBD study to focus exclusively on women’s health…
Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Cigna has released a national coverage policy for treatment of uterine fibroids with the Sonata System. The Sonata System uses radiofrequency energy to ablate fibroids under real time sonography guidance from within the uterine cavity, utilizing the first and only intrauterine ultrasound…
Fertility Focus, the manufacturers of the OvuCore and OvuSense Pro family of fertility monitoring solutions, today announces the launch of OvuFirst, a unique patented sensor designed to measure skin temperature, providing women with an understanding of when to try and conceive naturally, and enabling them to determine what issues they may have trying to conceive. OvuFirst is targeted at women who wish…
Auransa, an artificial intelligence (AI) company developing precision medicines in areas of unmet medical needs, and Polaris Quantum Biotech (POLARISqb), a quantum drug design company, announced a research collaboration addressing therapeutics for neglected diseases disproportionately affecting women. The partnership seeks to discover treatments that may tackle many such diseases, and their complementary expertise promises to seek solutions that elude medical research. Auransa…
Women’s health company Hologic has announced a new parntership with Cigna, one of the largest global health insurance service companies. Cigna has updated its medical policy to cover Hologic’s Acessa Laparoscopic Radiofrequency Ablation (Lap-RFA) procedure (CPT code 58674) as medically necessary. This new coverage further validates laparoscopic radiofrequency ablation (Lap-RFA) as a standard of care for uterine fibroids. The Acessa procedure can…
Period-care brand Callaly has launched “We Need to Talk About Vulvas”, a new campaign to encourage #VulvaTalk and debunk “the myth of the perfect vulva”, centering diverse, real life experiences of people with vulvas and providing new educational material for parents, educators and people with vulvas. The campaign launches with research showing almost a third (29%) of people aged 16 to 35…
Aphrodite Health, a new biotech company in the rapidly emerging multibillion dollar psychedelic medicine sector, launches today. Founded by women, and focused on addressing women’s mental and physical health with psychedelic enhanced treatments, the company has developed a two pronged approach, with a long term drug discovery program to bring an FDA approved drug to market. Aphrodite Health is a US-based psychedelic…
